Please login to the form below
Former Roche CEO joins BIAL board
Franz Humer to advise Portuguese pharma company
Portugal-based pharma company BIAL has appointed former Roche CEO Franz Humer as a non-executive member of its board.
Humer has vast experience in the pharma industry, spending 10 years as CEO of Swiss giant Roche from 1998 to 2008 and 13 years as chairman of its board of directors from 2001 to 2014 when he retired from the company.
In total he spent 19 years at Roche, where he also served as chief operating officer and head of its pharmaceutical division. This followed 15 years at Glaxo Holdings (now part of GSK) and 8 years at Schering Plough (now part of Merck & Co).
He will now advised BIAL which has a strong presence in southern Europe and in Latin America and is looking to grow internationally.
Luís Portela, chairman of BIAL, said: "It is an honour to count on the experience of Dr Franz Humer, who dedicated his professional career to the pharmaceutical industry in large multinational companies of innovation. His incorporation is especially relevant to BIAL as it is a recognition of the work we have been developing."
Featured jobs
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Senior Account Manager
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Account Manager / Account Director
-
Competative
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
-
Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Account Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
Cello Health
Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
